IP Library Patent Application 13852294
Patent Application
App. No. 13/852,294

BIOMIMETIC MEMBRANES AND USES THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/852,294
Abstract

A liquid membrane system is disclosed in the form of a biochannel containing bulk liquid membrane (BLM), biochannel containing emulsion liquid membrane (ELM), and biochannel containing supported (immobilised) liquid membrane (SLM), or a combination thereof, wherein said liquid membrane system is based on vesicles formed from amphiphilic compounds such as lipids forming a bilayer wherein biochannels have been incorporated and wherein said vesicles further contain a stabilising oil phase. The uses of the membrane system include water extraction from liquid aqueous media by forward osmosis, e.g. for desalination of salt water.

Claims (20)

1 . A liquid membrane system in the form of a bulk liquid membrane (BLM) containing a biochannel, an emulsion liquid membrane (ELM) containing a biochannel, or a supported (immobilised) liquid membrane (SLM), containing a biochannel,

wherein the liquid membrane system comprises vesicles, said vesicles being formed from one or more amphiphilic compounds, said amphiphilic compounds forming a bilayer into which the biochannels have been incorporated,

and wherein said liquid membrane system further comprises a stabilising oil phase that comprises squalene, squalane or a mixture thereof.

2 . The liquid membrane system according to claim 1 , wherein said biochannel is an aquaporin water channel.

3 . The liquid membrane system according to claim 1 , wherein the biochannel is selected from the group consisting of boron nitride nanotubes, carbon nanotubes, amphiphilic pore forming molecules including the transmembrane channel molecules beta-barrel pores such as alpha-hemolysin and OmpG, FomA, and VDAC; the transmembrane peptide pores alamethicin, valinomycin, and gramicidin A including derivatives thereof and synthetic peptides; ion channels, and ion-selective ionophores.

4 . The liquid membrane system according to claim 1 , wherein the amphiphilic compounds are lipids.

5 . The liquid membrane system according claim 1 , wherein the biochannels are present in a ratio of 1% to about 70% relative to the vesicle surface area.

6 . The liquid membrane system according to claim 1 which is contained or immobilised in a contactor module.

7 . The liquid membrane system of claim 6 , wherein the contactor module is selected from the group consisting of a flat sheet module, a hollow fibers separation module and a spiral wound separation module.

8 . The liquid membrane system of claim 6 , wherein the contactor module is a two module hollow fiber supported liquid membrane contactor module or a liquid cell extra-flow membrane contactor module.

9 . The liquid membrane system according to claim 1 which is contained or immobilised in a porous support layer.

10 . The liquid membrane system according to claim 2 which is capable of extracting water from liquid aqueous media by forward osmosis.

11 . The liquid membrane system according to claim 10 , wherein the liquid medium is salt water and the membrane system is used for desalination of salt water.

12 . The liquid membrane system according to claim 10 , wherein said forward osmosis process utilizes salt water as the feed solution and a CO 2 /NH 3 aqueous solution as the draw solution, and where elimination of the dissolved CO 2 and NH 3 gases is effected through heating to about 58° C.

13 . The liquid membrane system according to claim 10 , wherein the water is pure water.

14 . The liquid membrane system according to claim 2 , wherein the liquid medium is a dialysate resulting from haemodialysis and the membrane system is used in re-extracting water from the dialysate resulting from haemodialysis.

15 . A method for extracting pure water from an aqueous liquid media comprising contacting one or more liquid membranes according to claim 2 with an aqueous liquid medium thereby extracting pure water by forward osmosis.

16 . The method of claim 15 , wherein the aqueous liquid medium is salt water and the membrane system is used for desalination.

17 . The method of claim 15 , wherein said forward osmosis process utilizes salt water as the feed solution and a CO 2 /NH 3 aqueous solution as the draw solution, and where elimination of the dissolved CO 2 and NH 3 gases is effected through heating to about 58° C.

18 . The method of claim 15 , wherein the liquid medium is a dialysate resulting from haemodialysis and the membrane system is used in re-extracting water from the dialysate resulting from haemodialysis.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2015
From: JENSEN, PETER HOLME; HANSEN, JESPER SØNDERGAARD; VISSING, THOMAS; PERRY, MARK EDWARD; NIELSEN, CLAUS HELIX
To: AQUAPORIN A/S
Reel/Frame 037062/0190 →